Translating Guidelines and Clinical Trial Data to and ... - Amazon S3

More documents

Recommendations

Info

MRD on Day 29 of Induction PredictsBoth Early and Late FailurePOG9904+9905+9906Early RelapseLate Relapseree Survival ProbabilityRelapse-F1.00.90.80.70.60.50.40.30.20.10Negative (n=1588)Positive (n=383)P0.01%) (n=68)0.10P
CCR for Patients in the SR and HR GroupsAccording to Molecular Response Statusrobability of CCRPWeek 16 in Adult ALL PatientsOverall1.01.00.90.90.80.80.70.70.6Molecular0.6CR: 69% (n=384)0.5Molecular0.50.4Failure: 26% (n=120)0.40.30.30.20.10P
Page 1 and 2: Translating Guidelinesand Clinical
Page 3 and 4: Distribution of the Common Chromoso
Page 8 and 9: Case 1:13-cv-10020-MLW Document 1 F
Page 11 and 12: CCG-Modified Standard BFMInduction(
Page 13 and 14: EFS During 5 Years ofFollow-Up in A
Page 15 and 16: Maintenance• Daily mercaptopurine
Page 17 and 18: Risk Stratification: Pediatric, T-C
Page 19 and 20: “Targeted Therapy”Ph+ ALL in Ch
Page 21 and 22: Adolescents and Young AdultsInducti
Page 23 and 24: Algorithm for Treatment of BMRelaps
Page 25 and 26: Pre-BMT MRD PredictsPost-BMT Relaps
Page 27 and 28: Clofarabine, Etoposide, and CPM in
Page 29 and 30: Toll-Like Receptors• TLR are patt
Page 31 and 32: Translating Guidelines and Clinical
Page 33 and 34: 17. How often do you intend to use

Translating Guidelines and Clinical Trial Data to and ... - Amazon S3

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?